Brief: Orchestra Biomed To Receive Up To $21 Million In Proceeds From Acquisition Of Vivasure By Haemonetics
Jan 12 (Reuters) - Haemonetics Corp HAE.N: ORCHESTRA BIOMED TO RECEIVE UP TO $21 MILLION IN PROCEEDS FROM ACQUISITION OF VIVASURE BY HAEMONETICS Source text: ID:nGNX269v3M Further company coverage: HAE.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orchestra Biomed Holdings
See all newsBrief: Orchestra Biomed Announces Pricing Of Public Offering
Orchestra BioMed slides after starting equity offering
Brief: Orchestra Biomed Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Orchestra Biomed Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Orchestra BioMed Q2 revenue drops, net loss widens